The Space Between Reaction and Regulation
Collection Three
MDMA-Assisted Therapy Research
Structured, medically responsible clinical research — not an endorsement of unsupervised use.
20
Articles
20
Published
0
Coming Soon
The Discipline
A clinical research collection covering MDMA-assisted psychotherapy as a structured investigational treatment model for trauma and stress disorders. It surveys trial evidence, mechanisms, ethics, screening, and integration.
Within Nervous System Intelligence
This collection sits inside NSI because trauma treatment is nervous-system work. We treat this research seriously, cautiously, and with attention to what remains unknown.
Editorial disclaimer
This collection discusses regulated clinical research only. Nothing in these articles constitutes medical advice, endorsement of recreational or unsupervised MDMA use, or a suggestion that readers self-administer investigational medicines. MDMA-assisted therapy is being studied within specific, monitored clinical protocols and remains subject to ongoing regulatory review.
The articles
All 20 articles in this collection.
What Is MDMA-Assisted Therapy?
A clear distinction between a structured investigational treatment model and recreational MDMA use.
Why Researchers Became Interested in MDMA for Trauma Treatment
How changes in fear, affiliation, trust, and emotional processing may affect psychotherapy.
MDMA Is Not the Therapy
Why preparation, therapeutic support, integration, screening, and follow-up remain central.
Fear Processing During MDMA-Assisted Sessions
How researchers believe MDMA may alter the experience of approaching traumatic material.
The Amygdala, Threat Perception, and MDMA Research
What studies suggest — and what remains uncertain — about changes in fear-related brain activity.
Oxytocin and Social Connection in MDMA Research
Why increased feelings of openness or connection require careful clinical boundaries.
Can Someone Feel Safer Without Losing Awareness of Risk?
The therapeutic goal of reducing overwhelming fear while preserving judgment and agency.
MDMA-Assisted Therapy and the Window of Tolerance
Whether altered arousal may allow some people to engage with material that previously felt unmanageable.
Memory Reconsolidation and MDMA-Assisted Therapy
How revisiting memories in a different emotional context may influence their future meaning.
The Importance of Preparation Before Psychedelic-Assisted Treatment
Why expectations, informed consent, coping skills, history, and treatment goals matter.
Integration: What Happens After the Session?
How patients and clinicians make sense of insights, emotions, memories, and behavioral changes afterward.
Who May Not Be an Appropriate Candidate?
A discussion of cardiovascular risks, medication interactions, psychiatric screening, and other clinical considerations.
The Risk of Idealizing Altered States
Why an emotionally powerful experience should not automatically be interpreted as permanent healing or objective truth.
Therapeutic Suggestibility and Informed Consent
How clinicians must protect patients from suggestion, dependency, boundary violations, and implanted interpretations.
The Ethics of Touch in MDMA-Assisted Therapy
Why consent must be explicit, ongoing, documented, and revocable.
MDMA Research and Complex Trauma
Questions about whether findings translate equally across different trauma histories and clinical populations.
Why Clinical Setting Matters
How medical supervision, therapist training, emergency planning, and controlled dosing influence safety.
MDMA, the Nervous System, and Social Safety
How affiliation, trust, threat perception, and body awareness may intersect during treatment.
What MDMA-Assisted Therapy Research Cannot Yet Tell Us
Limitations involving long-term outcomes, generalizability, therapist effects, and access.
The Future of MDMA-Assisted Mental Healthcare
How this field may influence trauma treatment even as regulation, evidence, training, and ethics continue to evolve.